Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

被引:12
作者
Sun, Zhongwei [1 ,2 ]
Li, Feng [3 ]
Zhou, Xin [3 ]
Wang, Wen [1 ,2 ]
机构
[1] Cellular Biomed Grp, Shanghai, Peoples R China
[2] Cellular Biomed Grp, Cupertino, CA 95014 USA
[3] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Resp Med, Shanghai, Peoples R China
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2017年 / 126期
关键词
Medicine; Issue; 126; Chronic obstructive pulmonary disease; chronic bronchitis; emphysema; airflow limitation; lung parenchymal destruction; ozone exposure; BLACK CARBON PARTICLES; AIR-POLLUTION; ANIMAL-MODELS; LUNG DAMAGE; HOSPITAL ADMISSIONS; OXIDATIVE STRESS; WALL ATTENUATION; COPD; EMPHYSEMA; INFLAMMATION;
D O I
10.3791/56095
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and lung parenchymal destruction. It has a very high incidence in aging populations. The current conventional therapies for COPD focus mainly on symptom-modifying drugs; thus, the development of new therapies is urgently needed. Qualified animal models of COPD could help to characterize the underlying mechanisms and can be used for new drug screening. Current COPD models, such as lipopolysaccharide (LPS) or the porcine pancreatic elastase (PPE)-induced emphysema model, generate COPD-like lesions in the lungs and airways but do not otherwise resemble the pathogenesis of human COPD. A cigarette smoke (CS)-induced model remains one of the most popular because it not only simulates COPD-like lesions in the respiratory system, but it is also based on one of the main hazardous materials that causes COPD in humans. However, the time-consuming and labor-intensive aspects of the CS-induced model dramatically limit its application in new drug screening. In this study, we successfully generated a new COPD model by exposing mice to high levels of ozone. This model demonstrated the following: 1) decreased forced expiratory volume 25, 50, and 75/forced vital capacity (FEV25/FVC, FEV50/FVC, and FEV75/FVC), indicating the deterioration of lung function; 2) enlarged lung alveoli, with lung parenchymal destruction; 3) reduced fatigue time and distance; and 4) increased inflammation. Taken together, these data demonstrate that the ozone exposure (OE) model is a reliable animal model that is similar to humans because ozone overexposure is one of the etiological factors of COPD. Additionally, it only took 6-8 weeks, based on our previous work, to create an OE model, whereas it requires 3-12 months to induce the cigarette smoke model, indicating that the OE model might be a good choice for COPD research.
引用
收藏
页数:7
相关论文
共 46 条
[1]   COPD in the general population: Prevalence, incidence and survival [J].
Afonso, Ana S. M. ;
Verhamme, Katia M. C. ;
Sturkenboom, Miriam C. J. M. ;
Brusselle, Guy G. O. .
RESPIRATORY MEDICINE, 2011, 105 (12) :1872-1884
[2]  
[Anonymous], SCI REP UK
[3]   Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema [J].
Antunes, Mariana A. ;
Abreu, Soraia C. ;
Cruz, Fernanda F. ;
Teixeira, Ana Clara ;
Lopes-Pacheco, Migueias ;
Bandeira, Elga ;
Olsen, Priscilla C. ;
Diaz, Bruno L. ;
Takyia, Christina M. ;
Freitas, Isalira P. R. G. ;
Rocha, Nazareth N. ;
Capelozzi, Vera L. ;
Xisto, Debora G. ;
Weiss, Daniel J. ;
Morales, Marcelo M. ;
Rocco, Patricia R. M. .
RESPIRATORY RESEARCH, 2014, 15
[4]  
Bchir S., 2016, J CELL MOL MED, P1
[5]   Contribution of air pollution to COPD and small airway dysfunction [J].
Berend, Norbert .
RESPIROLOGY, 2016, 21 (02) :237-244
[6]   Role of matrix metalloproteinases in the inflammatory response in human airway cell-based assays and in rodent models of airway disease [J].
Birrell, Mark A. ;
Wong, Sissie ;
Dekkak, Abdel ;
De Alba, Jorge ;
Haj-Yahia, Saleem ;
Belvisi, Maria G. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02) :741-750
[7]   Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease [J].
Brusselle, Guy G. ;
Joos, Guy F. ;
Bracke, Ken R. .
LANCET, 2011, 378 (9795) :1015-1026
[8]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[9]   Epidemiology and costs of chronic obstructive pulmonary disease [J].
Chapman, KR ;
Mannino, DM ;
Soriano, B ;
Vermeire, PA ;
Buist, AS ;
Thun, MJ ;
Connell, C ;
Jemal, A ;
Lee, TA ;
Miravitlles, M ;
Aldington, S ;
Beasley, R .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (01) :188-207
[10]   Comparison of lung damage in mice exposed to black carbon particles and ozone-oxidized black carbon particles [J].
Chu, Hongqian ;
Shang, Jing ;
Jin, Ming ;
Li, Qian ;
Chen, Yueyue ;
Huang, Hongpeng ;
Li, Yuan ;
Pan, Yao ;
Tao, Xi ;
Cheng, Zhiyuan ;
Meng, Qinghe ;
Jia, Guang ;
Zhu, Tong ;
Wei, Xuetao ;
Hao, Weidong .
SCIENCE OF THE TOTAL ENVIRONMENT, 2016, 573 :303-312